Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19

[1]  Ali I. Al-Gareeb,et al.  Dantrolene and ryanodine receptors in COVID‐19: The daunting task and neglected warden , 2023, Clinical and experimental pharmacology & physiology.

[2]  Ali I. Al-Gareeb,et al.  Pathophysiology of Post-COVID syndromes: a new perspective , 2022, Virology Journal.

[3]  Ali I. Al-Gareeb,et al.  The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not? , 2022, Diagnostics.

[4]  Ali I. Al-Gareeb,et al.  COVID-19 and corticosteroids: a narrative review , 2022, Inflammopharmacology.

[5]  A. Salonia,et al.  Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis , 2022, Journal of Endocrinological Investigation.

[6]  Ali I. Al-Gareeb,et al.  High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons , 2022, Inflammopharmacology.

[7]  B. Aras,et al.  A factor not to be ignored in post‐COVID‐19 erectile dysfunction; psychological effect, a prospective study , 2022, Andrologia.

[8]  Ali I. Al-Gareeb,et al.  The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19 , 2022, Inflammation.

[9]  I. Sokolakis,et al.  Tip of the iceberg: erectile dysfunction and COVID-19 , 2022, International Journal of Impotence Research.

[10]  Ali I. Al-Gareeb,et al.  The possible role of ursolic acid in Covid-19: A real game changer , 2022, Clinical Nutrition ESPEN.

[11]  Ali I. Al-Gareeb,et al.  Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19 , 2021, Frontiers in Immunology.

[12]  Ali I. Al-Gareeb,et al.  Statins Therapy Improves Acute Ischemic Stroke in Patients with Cardio-metabolic Disorders Measured by Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): New Focal Point , 2021, Neurology India.

[13]  Jianlin Yuan,et al.  The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers , 2021, Sexual Medicine Reviews.

[14]  G. Batiha,et al.  Hypertension and its management in COVID-19 patients: The assorted view , 2021, International Journal of Cardiology Cardiovascular Risk and Prevention.

[15]  M. Uguccioni,et al.  The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases , 2021, Viruses.

[16]  F. O. Atanu,et al.  Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective , 2021, Biomedicine & Pharmacotherapy.

[17]  Ali I. Al-Gareeb,et al.  Testosterone in COVID-19: An Adversary Bane or Comrade Boon , 2021, Frontiers in Cellular and Infection Microbiology.

[18]  F. Brunello,et al.  Diagnosis of Male Central Hypogonadism During Childhood , 2021, Journal of the Endocrine Society.

[19]  Ali I. Al-Gareeb,et al.  Impact of Sitagliptin in Non-Diabetic Covid-19 Patients. , 2021, Current molecular pharmacology.

[20]  A. Isidori,et al.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments , 2021, Diabetes/metabolism research and reviews.

[21]  Ali I. Al-Gareeb,et al.  Levamisole Therapy in COVID-19. , 2021, Viral immunology.

[22]  A. Vallée,et al.  Clinical characterization of dysautonomia in long COVID-19 patients , 2021, Scientific Reports.

[23]  H. Azizi,et al.  Review of Sertoli cell dysfunction caused by COVID-19 that could affect male fertility. , 2021, Zygote.

[24]  Xun Li,et al.  Hypertension as a sequela in patients of SARS-CoV-2 infection , 2021, PloS one.

[25]  M. Ståhlberg,et al.  Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome , 2021, JACC: Case Reports.

[26]  É. Rousseau,et al.  PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking , 2021, Biochemical Pharmacology.

[27]  Sunil Krishnan,et al.  Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities , 2021, Reproductive Sciences.

[28]  Ali I. Al-Gareeb,et al.  Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm , 2021, ASN neuro.

[29]  A. V. Raveendran.  Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[30]  S. Okçelik.  COVID‐19 pneumonia causes lower testosterone levels , 2020, Andrologia.

[31]  Amish Talwar,et al.  A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. , 2020, JAMA.

[32]  M. Hayden.  An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms , 2020, Cells.

[33]  W. Lu,et al.  Impaired spermatogenesis in COVID-19 patients , 2020, EClinicalMedicine.

[34]  M. Rodriguez‐Barradas,et al.  Postacute COVID-19: An Overview and Approach to Classification , 2020, Open forum infectious diseases.

[35]  J. Mehta,et al.  Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19 , 2020, Journal of cardiovascular pharmacology and therapeutics.

[36]  Ali I. Al-Gareeb,et al.  COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors , 2020, Journal of microscopy and ultrastructure.

[37]  B. Kalyanaraman.  Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity? , 2020, Redox Biology.

[38]  N. Stergiopulos,et al.  Characterization of the Renin-Angiotensin System in Aged Cavernosal Tissue and its Role in Penile Fibrosis. , 2020, The journal of sexual medicine.

[39]  T. Greenhalgh,et al.  Management of post-acute covid-19 in primary care , 2020, BMJ.

[40]  V. Papadopoulos,et al.  Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone? , 2020, Andrology.

[41]  M. Marchetti.  COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure , 2020, Annals of Hematology.

[42]  Quanlong Jiang,et al.  Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation , 2020, Aging cell.

[43]  G. Russo,et al.  Impact of the COVID-19 pandemic on the sexual behavior of the population. The vision of the east and the west , 2020, International braz j urol : official journal of the Brazilian Society of Urology.

[44]  Ali I. Al-Gareeb,et al.  From SARS-CoV to nCoV-2019: Ruction and Argument , 2020, Archives of Clinical Infectious Diseases.

[45]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[46]  A. Isidori,et al.  Diagnostic and Therapeutic Workup of Erectile Dysfunction: Results From a Delphi Consensus of Andrology Experts , 2019, Sexual medicine.

[47]  S. Ima-Nirwana,et al.  The relationship between circulating testosterone and inflammatory cytokines in men , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

[48]  K. Gopalakrishnan,et al.  Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats† , 2018, Biology of Reproduction.

[49]  Hayder M Al-Kuraishy,et al.  Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice , 2018, Journal of advanced pharmaceutical technology & research.

[50]  Mohannad A. Awad,et al.  The association of bicycle‐related genital numbness and Sexual Health Inventory for Men (SHIM) score: results from a large, multinational, cross‐sectional study , 2018, BJU international.

[51]  M. Maggi,et al.  Testosterone and sexual function in men. , 2018, Maturitas.

[52]  B. J. Clark,et al.  Leydig cell insufficiency in hypospermatogenesis: a paracrine effect of activin–inhibin signaling? , 2018, Andrology.

[53]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[54]  E. Mannucci,et al.  Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. , 2017, European urology.

[55]  Ali I. Al-Gareeb,et al.  Erectile Dysfunction and Low Sex Drive in Men with Type 2 DM: The Potential Role of Diabetic Pharmacotherapy. , 2016, Journal of clinical and diagnostic research : JCDR.

[56]  G. Hankins,et al.  Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta , 2016, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[57]  Ali I. Al-Gareeb,et al.  Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients , 2016, Journal of intercultural ethnopharmacology.

[58]  F. Giuliano,et al.  Physiology and Pharmacology of Ejaculation. , 2016, Basic & clinical pharmacology & toxicology.

[59]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[60]  B. Alexander,et al.  Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[61]  F. Reis,et al.  Angiotensin (1–7) and its receptor Mas are expressed in the human testis: implications for male infertility , 2010, Journal of Molecular Histology.

[62]  R. Segraves.  Considerations for diagnostic criteria for erectile dysfunction in DSM V. , 2010, The journal of sexual medicine.

[63]  P. Navukkarasu,et al.  Autonomic dysfunction in cardiovascular system of type 2 diabetic mellitus – A bedside evaluation , 2010 .

[64]  J. Cappelleri,et al.  The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience , 2005, International Journal of Impotence Research.

[65]  A Ian Smith,et al.  The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. , 2004, Endocrinology.

[66]  M. Ozata,et al.  The effects of metformin and diet on plasma testosterone and leptin levels in obese men. , 2001, Obesity research.

[67]  P. Madden.  The Swedish experience. , 1988, The Health service journal.

[68]  H. Farmer.  A new perspective. , 1988, The Journal of the Florida Medical Association.